Cytokeratin 14 in Ocular Cicatricial Pemphigoid and Chronic Cicatrizing Conjunctivitis
M. Meniconi(Massachusetts Eye and Ear Infirmary), C. Stephen Foster(Massachusetts Eye and Ear Infirmary), Mohammed S. Razzaque(The University of Texas Rio Grande Valley), Sofia Androudi(University of Thessaly), A. R. Ahmed(Nirma University)
Investigative Ophthalmology & Visual Science
May 1, 2004
Cited by 0
Related Papers
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|5k
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
|The Lancet Global Health|2020|1.3k
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin
|New England Journal of Medicine|2006|452
Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris.
|Proceedings of the National Academy of Sciences|1995|249